Latest News
Douglas Venters Joins QV as Senior Project Engineer
Welcome to the newest Team Member! ?? Douglas Venters Delighted to announce Doug is joining the QV Bioelectronics team as a Senior…
Read More
QV Bioelectronics Raises £2m to Develop Revolutionary Electric Field Therapy Implant for Brain Tumour Treatment
10th January 2022, Cheshire, UK £2M Pre-Series A financing raised from new and existing VCs. The funds will facilitate the completion…
Read More
Sabine Ficek Joins QV Bio as new CFO
We are delighted to announce that Sabine Ficek has joined our growing team QV Bioelectronics as CFO! Sabine is a seasoned CFO with 25…
Read More
QV Bioelectronics CEO Dr Chris Bullock Gives Evidence as an Industry Expert to the All-Party Parliamentary Group on Brain Tumours (APPGBT)
The All-Party Parliamentary Group on Brain Tumours (APPGBT) held a fifth oral evidence session today as part of its ongoing inquiry, Pathway to…
Read More
QV Bioelectronics Awarded £630,000 Under Innovate UK Biomedical Catalyst Award for implanted electric field therapy device for brain cancer treatment.
Funding will accelerate development of the GRACE implant to treat brain tumour patients with electric field therapy. The project…
Read More
Liz Freeman Joins QV as Finance/HR Manager
We’re delighted to welcome our newest addition to the team ?Liz Freeman!? Liz is an experienced Finance/HR Manager and brings…
Read More@qvbio
@InnovateUK & @UKinTX hosted @michelledonelan on her visit to @TXMedCenter to meet the latest cohort of UK-based #DigitalHealth & #Medical device startups participating in the TMC Innovation accelerator, part of Innovate UK's Global Incubator Programme.
⚕️https://ow.ly/5vwI50Q8EP1
Now Presenting: Christopher Bullock of @qvbio (Cheshire, UK). They are developing the world’s first implantable electric field therapy device to treat aggressive brain cancers.
Are you staying informed?
http://bit.ly/3G0kLGa
🎉Presenting in the #Oncology Therapeutic Category at Innovation Summit San Francisco 2023 is Presenting Company QV Bioelectronics (@qvbio) with CEO Christopher Bullock.
🎉 Welcome to #InnovationSF23, Chris and the QV Bioelectronics team! We are delighted to have you.
@qvbio and @IncubateBio announce successful outcome of strategic collaboration to accelerate new treatment option for Glioblastoma
Our IDH mutant glioma heterogeneity paper with @hoheyn is out in @CellRepMed. A wonderful collective effort by @Enblacar, Ashwin, Inma, and @JuanCNieto1. Special thanks to Matthias and Luigi. Looking forward to expanding on this work!